FDA Reverses Course, Decides Now Might Not Be The Time To Close Half Its Field Labs

FDA Reverses Course, Decides Now Might Not Be The Time To Close Half Its Field Labs

Bowing to pressure from Congress, the FDA has decided not to close more than half of its field labs. The ill-timed plan to consolidate seven of the agency’s thirteen labs in the name of efficiency and modernization was already under review by a Presidential panel, and had raised the ire of the powerful Chairman of the House Energy and Commerce Committee, John Dingell, who recently introduced legislation to block the reorganization.